索霍最新技术更新和下一个问题 解决侵略性B细胞淋巴瘤的变革性问题
Gonca Ozcan1, Mark Roschewski1
1Lymphoid Malignancies Branch, Center for Cancer Research, NCI, Bethesda, MD.
Clinical lymphoma, myeloma & leukemia
|February 28, 2026
概括
改善大B细胞淋巴瘤 (LBCL) 患者的治疗结果至关重要. 研究探讨免疫疗法,精准医学,无化疗选择和ctDNA监测,以提高前线治愈率和治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 大型B细胞淋巴瘤 (LBCL) 是一种严重的血液性恶性瘤.
- 目前的基于 antracycline 的化学免疫疗法为大多数人提供治疗方法,但很少有人面临耐药性疾病或复发.
- 提高LBCL的前线治愈率是淋巴瘤研究的一个关键目标.
研究的目的:
- 讨论LBCL标准化疗之外的新型治疗策略.
- 解决有关免疫疗法,精准医学,无化疗方案和ctDNA在LBCL治疗中的关键问题.
- 探索改善前线结果和LBCL未来治疗范式的不断发展的战略.
主要方法:
- 文献审查和讨论新兴的治疗方法.
- 分析免疫疗法在前线LBCL治疗中的潜在作用.
- 对精准医学进行评估,以解决LBCL的遗传异质性.
- 探索LBCL的无化疗治疗可能性.
- 在LBCL中评估循环瘤DNA (ctDNA) 以适应应答应的策略.
主要成果:
- 讨论强调了免疫疗法的潜力,以提高LBCL的前线治愈率.
- 精准医学被认为是管理LBCL遗传多样性的可行方法.
- 没有化疗的LBCL治愈策略的可行性正在调查中.
- 目前正在探索ctDNA在指导LBCL治疗决策中的有用性.
结论:
- 涉及免疫疗法,精准医学和ctDNA监测的新兴策略显示,改善LBCL结果具有前途.
- 这些不断发展的方法可能会重新定义LBCL患者的前线治疗模式.
- 进一步的研究对于将这些新的策略纳入LBCL的标准临床实践至关重要.
更多相关视频
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
27.4K
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.9K
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
B Cell Activation and Differentiation
17.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.4K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Tumor Progression
7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Bone Marrow Sampling and Transplants
1.8K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K
